The study for the effect of FXIII substitution on intra- and postoperative bleeding in hepatobiliary surgery.

The study for the effect of FXIII substitution on intra- and postoperative bleeding in hepatobiliary surgery. - FXIII and intra- and postoperative bleeding

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014416

Enrollment

Registered

2014-08-01

Start date

2014-07-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are going to undergo hepatectomy and pancreaticoduodenectomy

Interventions

supplementation of FXIII non-supplementation of FXIII

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who are going to undergo hepatectomy or pancreaticoduodenectomy. The patients who agreed to participate this study.

Exclusion criteria

Exclusion criteria: The patients who refuse to participate this study. The patients who are not eligible to participate this study that is defined by responsible physicians.

Design outcomes

Primary

Measure	Time frame
Perioperative FXIII activity. The extent of intra- and postoperative bleeding and blood transfusion.	—

Secondary

Measure	Time frame
The amount of postoperative drain volume and hemoglobin concentration. The incidence rate of postoperative liver failure, bile leakage, pancreatic fistula, anastomotic failure, and infectious complications.	—

Countries

Japan

Contacts

Public ContactYukihiro Yokoyama

Nagoya University Hospital Surgery 1

yyoko@med.nagoya-u.ac.jp+81-527442222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026